Trademark Overview
On Wednesday, November 27, 2024, a trademark application was filed for CENTER FOR PHARMACOECONOMICS with the United States Patent and Trademark Office. The USPTO has given the CENTER FOR PHARMACOECONOMICS trademark a serial number of 98876461. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 27, 2024. This trademark is owned by Leerink Intermediate Holdings LLC. The CENTER FOR PHARMACOECONOMICS trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Insurance & Financial Services, and Education & Entertainment Services categories with the following description:
Online non-downloadable content related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring non-downloadable instructional videos, webinars and podcasts related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring non-downloadable instructional videos, webinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance
Downloadable reports, newsletters and educational materials related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Downloadable software related to business information, financial information, and consulting for the same; Downloadable computer software and downloadable mobile applications for use in investment banking and management, accessing and conducting banking and financial business, and obtaining information, research, analysis, and advice in the fields of investments, banking, and financial services
Financial services, namely consulting and advising related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Financial consulting; Investment advisory and consulting services; Financial services, namely, investment advice, investment management, investment consultation; Information, advisory, consultancy and financial research services relating to finance and investments
Business consulting; Business advisory; Acquisition and merger consultation; Providing trade information; Compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; Business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; Business consultation services, namely, business evaluation regarding firms in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology
